Complementary vascular and matrix regulatory pathways underlie the beneficial mechanism of action of sorafenib in liver fibrosis
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Gwen Lomberk |
| Publication date | June 26, 2011 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |